Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Beacon Financial Corporation
BBT·Financials
B ★★★Hold
Current$30.62
Target$34.00
Return+11.0%
Oct 31, 2026

Beacon Financial offers improving merger-driven profitability, a meaningful dividend, and reasonable forward valuation, but contracting loans and deposits and rising problem assets threaten sustainable earnings growth.

Score
66
Establishment Labs Holdings Inc.
ESTA·Healthcare
B ★★★Hold
Current$62.46
Target$71.20
Return+14.0%
Oct 31, 2026

Establishment Labs can compound revenue through U.S. Motiva adoption and minimally invasive innovation, but its premium valuation, substantial debt, and unproven cash-flow durability limit the margin of safety.

Score
70
Wix.com Ltd.
WIX·Technology
B ★★★Hold
Current$77.07
Target$100.00
Return+29.8%
Oct 31, 2026

Wix combines a sticky subscription software franchise with AI-driven growth potential and attractive cash-flow valuation, but Base44 execution risk, declining FCF margins, and increased leverage constrain near-term conviction.

Score
72
OneSpaWorld Holdings Limited
OSW·Consumer Discretionary
B ★★★Hold
Current$30.22
Target$32.40
Return+7.2%
Oct 31, 2026

OneSpaWorld combines a defensible cruise-spa network, rising guest spending, and improving cash generation, but its elevated valuation leaves limited protection against slower growth or weaker cruise demand.

Score
65
TriNet Group, Inc.
TNET·Industrials
B ★★★Hold
Current$64.28
Target$68.60
Return+6.7%
Oct 31, 2026

TriNet combines recurring HR outsourcing revenue, strong free cash flow, and shareholder returns with a potentially attractive valuation, but persistent workforce contraction and volatile insurance economics constrain its recovery outlook.

Score
69
DHT Holdings, Inc.
DHT·Energy
B ★★★Hold
Current$25.02
Target$25.50
Return+1.9%
Oct 31, 2026

DHT combines exceptional VLCC freight earnings, strong cash generation, and shareholder distributions with a disciplined balance sheet, but cyclical rate normalization and elevated fleet valuations constrain long-term upside.

Score
71
Arcutis Biotherapeutics, Inc.
ARQT·Healthcare
B ★★★Hold
Current$32.07
Target$38.11
Return+18.8%
Oct 31, 2026

Arcutis offers sustained dermatology-drug growth and expanding profitability through ZORYVE, but dependence on one franchise, reimbursement pressure, dilution, and a premium valuation limit the margin of safety.

Score
73
United States Lime & Minerals, Inc.
USLM·Materials
B ★★★Hold
Current$111.61
Target$114.40
Return+2.5%
Oct 31, 2026

United States Lime & Minerals combines strong regional competitive advantages, exceptional profitability, and a debt-light balance sheet, but slower growth and Texas kiln execution risks constrain near-term valuation upside.

Score
72
Hawkins, Inc.
HWKN·Materials
B ★★★Hold
Current$152.53
Target$155.10
Return+1.7%
Oct 31, 2026

Hawkins combines resilient municipal water treatment demand, disciplined acquisitions, and strong cash conversion, but its premium valuation requires sustained organic growth and successful integration to justify attractive future returns.

Score
66
Green Brick Partners, Inc.
GRBK·Consumer Discretionary
B ★★★Hold
Current$60.86
Target$67.10
Return+10.3%
Oct 31, 2026

Green Brick Partners offers attractive land-development economics, strong historical margins, and conservative leverage, but falling home prices and inventory-driven cash-flow weakness could delay an earnings recovery.

Score
68
The St. Joe Company
JOE·Real Estate
B ★★★Hold
Current$70.02
Target$72.00
Return+2.8%
Oct 31, 2026

St. Joe's scarce Northwest Florida landholdings and expanding hospitality operations support long-term value creation, but premium earnings multiples and geographically concentrated real estate risks constrain near-term upside.

Score
72